The global Glabridin market was valued at US$ 37.74 million in 2024 and is anticipated to reach US$ 59.43 million by 2031, witnessing a CAGR of 6.84% during the forecast period 2025-2031.
North American market for Glabridin is estimated to increase from $5.96 million in 2024 to reach $9.20 million by 2031, at a CAGR of 6.35% during the forecast period of 2024 through 2031.
Asia-Pacific market for Glabridin is estimated to increase from $21.09 million in 2024 to reach $33.86 million by 2031, at a CAGR of 7.17% during the forecast period of 2024 through 2031.
The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glabridin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glabridin.
The Glabridin market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glabridin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glabridin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Sabinsa
- Mafco
- Maruzen Pharmaceuticals
- Hyundai Bioland
- Shanghai OLI
- Lepro Herbals
- Gansu Fanzhi Pharmaceutical
- Qinghai Lake Pharmaceutical
- Hangzhou Lingeba Technology
- Shaanxi Huatai Bio
- Huzhou Ouli Biological Technology
- Plamed Green Science Group
- Xi'an Zhongying
- Huaian Brothers Biotechnology
- Alchem International
- Ambe Phytoextracts
- Sunpure Extracts
- Novel Nutrientss
Segment by Type
- Up to 20% (HPLC)
- 40% (HPLC)
- 60% (HPLC)
- 90% (HPLC)
- 98% (HPLC)
Segment by Application
- Creams and Lotions
- Masks
- Sunscreen Products
- Others
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Southeast Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Middle East & Africa
- GCC Countries
- Turkey
- Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glabridin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glabridin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Glabridin Market Overview
- 1.1 Product Definition
- 1.2 Glabridin by Type
- 1.3 Glabridin by Application
- 1.3.1 Global Glabridin Market Value by Application (2025-2031)
- 1.3.2 Creams and Lotions
- 1.3.3 Masks
- 1.3.4 Sunscreen Products
- 1.3.5 Others
- 1.4 Global Glabridin Market Size Estimates and Forecasts
- 1.4.1 Global Glabridin Revenue 2020-2031
- 1.4.2 Global Glabridin Sales 2020-2031
- 1.4.3 Global Glabridin Market Average Price (2020-2031)
- 1.5 Assumptions and Limitations
2 Glabridin Market Competition by Manufacturers
- 2.1 Global Glabridin Sales Market Share by Manufacturers (2020-2025)
- 2.2 Global Glabridin Revenue Market Share by Manufacturers (2020-2025)
- 2.3 Global Glabridin Average Price by Manufacturers (2020-2025)
- 2.4 Global Key Players of Glabridin, Industry Ranking, 2023 VS 2024 VS 2025
- 2.5 Global Key Manufacturers of Glabridin, Manufacturing Sites & Headquarters
- 2.6 Global Key Manufacturers of Glabridin, Product Type & Application
- 2.7 Global Key Manufacturers of Glabridin, Date of Establishment in This Industry
- 2.8 Global Glabridin Market Competitive Situation and Trends
- 2.8.1 Global Glabridin Market Concentration Rate
- 2.8.2 The Global 3 and 6 Largest Glabridin Players Market Share by Revenue
- 2.8.3 Global Glabridin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3 Global Glabridin Market Scenario by Region
- 3.1 Global Glabridin Market Size by Region: 2020 Versus 2024 Versus 2031
- 3.2 Global Glabridin Sales by Region: 2020-2031
- 3.2.1 Global Glabridin Sales by Region: 2020-2025
- 3.2.2 Global Glabridin Sales by Region: 2026-2031
- 3.3 Global Glabridin Revenue by Region: 2020-2031
- 3.3.1 Global Glabridin Revenue by Region: 2020-2025
- 3.3.2 Global Glabridin Revenue by Region: 2026-2031
- 3.4 North America Glabridin Market Facts & Figures by Country
- 3.4.1 North America Glabridin Market Size by Country: 2020 VS 2024 VS 2031
- 3.4.2 North America Glabridin Sales by Country (2020-2031)
- 3.4.3 North America Glabridin Revenue by Country (2020-2031)
- 3.4.4 United States
- 3.4.5 Canada
- 3.5 Europe Glabridin Market Facts & Figures by Country
- 3.5.1 Europe Glabridin Market Size by Country: 2020 VS 2024 VS 2031
- 3.5.2 Europe Glabridin Sales by Country (2020-2031)
- 3.5.3 Europe Glabridin Revenue by Country (2020-2031)
- 3.5.4 Germany
- 3.5.5 France
- 3.5.6 U.K.
- 3.5.7 Italy
- 3.5.8 Spain
- 3.6 Asia Pacific Glabridin Market Facts & Figures by Region
- 3.6.1 Asia Pacific Glabridin Market Size by Region: 2020 VS 2024 VS 2031
- 3.6.2 Asia Pacific Glabridin Sales by Region (2020-2031)
- 3.6.3 Asia Pacific Glabridin Revenue by Region (2020-2031)
- 3.6.4 China
- 3.6.5 Japan
- 3.6.6 South Korea
- 3.6.7 India
- 3.6.8 Southeast Asia
- 3.6.9 Australia
- 3.7 Latin America Glabridin Market Facts & Figures by Country
- 3.7.1 Latin America Glabridin Market Size by Country: 2020 VS 2024 VS 2031
- 3.7.2 Latin America Glabridin Sales by Country (2020-2031)
- 3.7.3 Latin America Glabridin Revenue by Country
- 3.7.4 Mexico
- 3.7.5 Brazil
- 3.8 Middle East and Africa Glabridin Market Facts & Figures by Region
- 3.8.1 Middle East and Africa Glabridin Market Size by Region: 2020 VS 2024 VS 2031
- 3.8.2 Middle East and Africa Glabridin Sales by Region (2020-2031)
- 3.8.3 Middle East and Africa Glabridin Revenue by Region
- 3.8.4 GCC Countries
- 3.8.5 Turkey
- 3.8.6 Africa
4 Segment by Type
- 4.1 Global Glabridin Sales by Type (2020-2031)
- 4.1.1 Global Glabridin Sales by Type (2020-2025)
- 4.1.2 Global Glabridin Sales by Type (2026-2031)
- 4.1.3 Global Glabridin Sales Market Share by Type (2020-2031)
- 4.2 Global Glabridin Revenue by Type (2020-2031)
- 4.2.1 Global Glabridin Revenue by Type (2020-2025)
- 4.2.2 Global Glabridin Revenue by Type (2026-2031)
- 4.2.3 Global Glabridin Revenue Market Share by Type (2020-2031)
- 4.3 Global Glabridin Price by Type (2020-2031)
5 Segment by Application
- 5.1 Global Glabridin Sales by Application (2020-2031)
- 5.1.1 Global Glabridin Sales by Application (2020-2025)
- 5.1.2 Global Glabridin Sales by Application (2026-2031)
- 5.1.3 Global Glabridin Sales Market Share by Application (2020-2031)
- 5.2 Global Glabridin Revenue by Application (2020-2031)
- 5.2.1 Global Glabridin Revenue by Application (2020-2025)
- 5.2.2 Global Glabridin Revenue by Application (2026-2031)
- 5.2.3 Global Glabridin Revenue Market Share by Application (2020-2031)
- 5.3 Global Glabridin Price by Application (2020-2031)
6 Key Companies Profiled
- 6.1 Sabinsa
- 6.1.1 Sabinsa Company Information
- 6.1.2 Sabinsa Description and Business Overview
- 6.1.3 Sabinsa Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Sabinsa Glabridin Product Portfolio
- 6.1.5 Sabinsa Recent Developments/Updates
- 6.2 Mafco
- 6.2.1 Mafco Company Information
- 6.2.2 Mafco Description and Business Overview
- 6.2.3 Mafco Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Mafco Glabridin Product Portfolio
- 6.3 Maruzen Pharmaceuticals
- 6.3.1 Maruzen Pharmaceuticals Company Information
- 6.3.2 Maruzen Pharmaceuticals Description and Business Overview
- 6.3.3 Maruzen Pharmaceuticals Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Maruzen Pharmaceuticals Glabridin Product Portfolio
- 6.4 Hyundai Bioland
- 6.4.1 Hyundai Bioland Company Information
- 6.4.2 Hyundai Bioland Description and Business Overview
- 6.4.3 Hyundai Bioland Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Hyundai Bioland Glabridin Product Portfolio
- 6.5 Shanghai OLI
- 6.5.1 Shanghai OLI Company Information
- 6.5.2 Shanghai OLI Description and Business Overview
- 6.5.3 Shanghai OLI Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Shanghai OLI Glabridin Product Portfolio
- 6.6 Lepro Herbals
- 6.6.1 Lepro Herbals Company Information
- 6.6.2 Lepro Herbals Description and Business Overview
- 6.6.3 Lepro Herbals Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Lepro Herbals Glabridin Product Portfolio
- 6.7 Gansu Fanzhi Pharmaceutical
- 6.7.1 Gansu Fanzhi Pharmaceutical Company Information
- 6.7.2 Gansu Fanzhi Pharmaceutical Description and Business Overview
- 6.7.3 Gansu Fanzhi Pharmaceutical Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Gansu Fanzhi Pharmaceutical Glabridin Product Portfolio
- 6.8 Qinghai Lake Pharmaceutical
- 6.8.1 Qinghai Lake Pharmaceutical Company Information
- 6.8.2 Qinghai Lake Pharmaceutical Description and Business Overview
- 6.8.3 Qinghai Lake Pharmaceutical Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 Qinghai Lake Pharmaceutical Glabridin Product Portfolio
- 6.9 Hangzhou Lingeba Technology
- 6.9.1 Hangzhou Lingeba Technology Company Information
- 6.9.2 Hangzhou Lingeba Technology Description and Business Overview
- 6.9.3 Hangzhou Lingeba Technology Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.9.4 Hangzhou Lingeba Technology Glabridin Product Portfolio
- 6.10 Shaanxi Huatai Bio
- 6.10.1 Shaanxi Huatai Bio Company Information
- 6.10.2 Shaanxi Huatai Bio Description and Business Overview
- 6.10.3 Shaanxi Huatai Bio Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.10.4 Shaanxi Huatai Bio Glabridin Product Portfolio
- 6.11 Huzhou Ouli Biological Technology
- 6.11.1 Huzhou Ouli Biological Technology Company Information
- 6.11.2 Huzhou Ouli Biological Technology Description and Business Overview
- 6.11.3 Huzhou Ouli Biological Technology Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.11.4 Huzhou Ouli Biological Technology Glabridin Product Portfolio
- 6.12 Plamed Green Science Group
- 6.12.1 Plamed Green Science Group Company Information
- 6.12.2 Plamed Green Science Group Description and Business Overview
- 6.12.3 Plamed Green Science Group Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.12.4 Plamed Green Science Group Glabridin Product Portfolio
- 6.13 Xi'an Zhongying
- 6.13.1 Xi'an Zhongying Company Information
- 6.13.2 Xi'an Zhongying Description and Business Overview
- 6.13.3 Xi'an Zhongying Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.13.4 Xi'an Zhongying Glabridin Product Portfolio
- 6.14 Huaian Brothers Biotechnology
- 6.14.1 Huaian Brothers Biotechnology Company Information
- 6.14.2 Huaian Brothers Biotechnology Description and Business Overview
- 6.14.3 Huaian Brothers Biotechnology Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.14.4 Huaian Brothers Biotechnology Glabridin Product Portfolio
- 6.15 Alchem International
- 6.15.1 Alchem International Company Information
- 6.15.2 Alchem International Description and Business Overview
- 6.15.3 Alchem International Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.15.4 Alchem International Glabridin Product Portfolio
- 6.16 Ambe Phytoextracts
- 6.16.1 Ambe Phytoextracts Company Information
- 6.16.2 Ambe Phytoextracts Description and Business Overview
- 6.16.3 Ambe Phytoextracts Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.16.4 Ambe Phytoextracts Glabridin Product Portfolio
- 6.17 Sunpure Extracts
- 6.17.1 Sunpure Extracts Company Information
- 6.17.2 Sunpure Extracts Description and Business Overview
- 6.17.3 Sunpure Extracts Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.17.4 Sunpure Extracts Glabridin Product Portfolio
- 6.18 Novel Nutrientss
- 6.18.1 Novel Nutrientss Company Information
- 6.18.2 Novel Nutrientss Description and Business Overview
- 6.18.3 Novel Nutrientss Glabridin Sales, Revenue and Gross Margin (2020-2025)
- 6.18.4 Novel Nutrientss Glabridin Product Portfolio
7 Industry Chain and Sales Channels Analysis
- 7.1 Glabridin Industry Chain Analysis
- 7.2 Glabridin Raw Material Supply Analysis
- 7.2.1 Key Raw Materials
- 7.2.2 Raw Materials Key Suppliers
- 7.3 Glabridin Production Mode & Process Analysis
- 7.4 Glabridin Sales and Marketing
- 7.4.1 Glabridin Sales Channels
- 7.4.2 Glabridin Distributors
- 7.5 Glabridin Customer Analysis
8 Glabridin Market Dynamics
- 8.1 Glabridin Industry Trends
- 8.2 Glabridin Market Drivers
- 8.3 Glabridin Market Challenges
- 8.4 Glabridin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.1.1 Research Programs/Design
- 10.1.2 Market Size Estimation
- 10.1.3 Market Breakdown and Data Triangulation
- 10.2 Data Source
- 10.2.1 Secondary Sources
- 10.2.2 Primary Sources
- 10.3 Author List
- 10.4 Disclaimer 124